Showing results (111-120 of 146) with videos related to
Sort By:
Pageof 15
Psychopharmacology|January 1, 1981
Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activityM G Ondrusek, C D Kilts, G D Frye, et al.Biological Psychiatry|December 4, 1998
Serotonergic basis of antipsychotic drug effects in schizophreniaJ A Lieberman, R B Mailman, G Duncan, et al.Brain Research|April 14, 1978
Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neuronsR J Konkol, R B Mailman, E G Bendeich, et al.Journal of Medicinal Chemistry|December 9, 1994
Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonistsD L Minor, S D Wyrick, P S Charifson, et al.Brain Research|February 21, 1994
Comparison of intracranial infusions of colchicine and ibotenic acid as models of neurodegeneration in the basal forebrainL W Shaughnessy, S Barone, W R Mundy, et al.Psychopharmacology|January 1, 1986
Pharmacological modification of DDT-induced tremor and hyperthermia in rats: distributional factorsD W Herr, J S Hong, P Chen, et al.Journal of Medicinal Chemistry|January 5, 1996
Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mappingD M Mottola, S Laiter, V J Watts, et al.Neuroscience|August 6, 1998
Behavioural assessment of mice lacking D1A dopamine receptorsD R Smith, C D Striplin, A M Geller, et al.Journal of Medicinal Chemistry|March 12, 1999
Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quineloraneM K Doll, D E Nichols, J D Kilts, et al.Journal of Medicinal Chemistry|September 1, 1989
Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligandsP S Charifson, J P Bowen, S D Wyrick, et al.Pageof 15